The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trials

Journal of Allergy and Clinical Immunology

Volumn 131, Issue 3, 2013, Pages

  Rank, Matthew A ^a   Hagan, John B ^a   Park, Miguel A ^a   Podjasek, Jenna C ^a   Samant, Shefali A ^a   Volcheck, Gerald W ^a   Erwin, Patricia J ^a   West, Colin P ^a  

^a MAYO CLINIC   (United States)

Author keywords

antiasthma agents; Asthma; cessation; clinical trial; decrease; discontinue; glucocorticoids; step down; wean; withdraw

Indexed keywords

CORTICOSTEROID;

ARTICLE; ASTHMA; DISEASE EXACERBATION; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LOW DRUG DOSE; META ANALYSIS; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

EID: 84875230783     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.11.038     Document Type: Article

References (21)

1. National Institutes of Health, Factbook Fiscal Year 2011. Available at: http://www.nhlbi.nih.gov/about/factbook/FactBook2011.pdf. Accessed April 22, 2012.
2. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Available at: http://www.nhlbi.nih.gov/about/naepp/. Accessed January 15, 2012.
3. Global Initiative for Asthma. Global strategy for asthma management and prevention 2011 update. Available at: http://www.ginasthma.org/uploads/users/ files/GINA-Report-2011.pdf. Accessed January 15, 2012.
4. D. Moher, A. Liberati, J. Telzlaff, and D.G. Altman PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 B2535
5. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. Accessed March 1, 2012.
6. W.E. Berger, E.R. Bleeker, L. O'Dowd, C.J. Miller, and W. Mezzanotte Efficacy and safety of budesonide/formoterol pressured metered-dose inhaler: randomized controlled trial comparing once-and twice-daily dosing in patients with asthma Allergy Asthma Proc 31 2010 49 59
7. J.J. Condemi, P. Chervinsky, M.F. Goldstein, L.B. Ford, W.E. Berger, and G.H. Ayars Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma J Allergy Clin Immunol 100 1997 467 474
8. T. Haahtela, M. Jarvinen, T. Kava, K. Kiviranta, S. Koskinen, and K. Lehtonen Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma N Engl J Med 331 1994 700 705
9. 2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial JAMA 285 2001 2583 2593
10. F.D. Martinez, V.M. Chinchilli, W.J. Morgan, S.J. Boehmer, R.F. Lemanske Jr., and D.T. Mauger Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomized, double-blind, placebo-controlled trial Lancet 377 2011 650 657
11. A. Papi, G.W. Canonica, P. Maestrelli, P. Paggiaro, D. Olivieri, and E. Pozzi Rescue use of beclomethasone and albuterol in a single inhaler for asthma N Engl J Med 356 2007 2040 2052
12. H.J. Waalkens, E.E. Van Essen-Zandvliet, M.D. Hughes, J. Gerritsen, E.J. Duiverman, and K. Knol Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration Am Rev Respir Dis 148 1993 1252 1257
13. S.J. Fowler, G.P. Currie, and B.J. Lipworth Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone J Allergy Clin Immunol 109 2002 929 935
14. E.D. Bateman, L. Jacques, C. Goldrad, T. Atienza, T. Mihaescu, and M. Duggan Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down J Allergy Clin Immunol 117 2006 563 570
15. S.M. Koenig, N. Ostrom, D. Pearlman, K. Waitkus-Edwards, S. Yancey, and B.A. Prillaman Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down. " J Asthma 45 2008 681 687
16. P. Godard, P. Greillier, B. Pigearias, G. Nachbaur, J.L. Desfougeres, and V. Attali Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomized study Respir Med 102 2008 1124 1131
17. H.K. Reddel, P.G. Gibson, M.J. Peters, P.A. Wark, I.B. Sand, and C.M. Hoyos Down-titration from high-dose combination therapy in asthma: removal of long-acting beta(2)-agonist Respir Med 104 2010 1110 1120
18. S.P. Peters, N. Anthonisen, M. Castro, J.T. Holbrook, C.G. Irvin, and L.J. Smith Randomized comparison of strategies for reducing treatment in mild persistent asthma N Engl J Med 356 2007 2027 2039
19. M.B. Drummond, S.P. Peters, M. Castro, J.T. Holbrook, C.G. Irvin, and L.J. Smith Risk factors for montelukast treatment failure in step-down therapy for controlled asthma J Asthma 48 2011 1051 1057
20. A. Deykin, M.E. Wechsler, H.A. Boushey, V.M. Chinchilli, S.J. Kunselman, and T.J. Craig Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma Am J Respir Crit Care Med 175 2007 228 234
21. W.W. Busse, W.J. Morgan, V. Taggart, and A. Togias Standardizing asthma outcomes in clinical research: report of the asthma outcomes workshop J Allergy Clin Immunol 129 suppl 2012 S1 S141